Impact of troponins on the evaluation and treatment of patients with acute coronary syndromes
- 1 July 1999
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Cardiology
- Vol. 14 (4) , 310-313
- https://doi.org/10.1097/00001573-199907000-00006
Abstract
Cardiac troponins possess superior sensitivity and specificity for the detection of cardiac injury. They can be used successfully to replace measurements of MB isoenzyme of creatine kinase or lactate dehydrogenase for the retrospective diagnosis of myocardial infarction. Measurement of these proteins confers powerful prognostic information that can be used to triage patients. An increasing body of data suggests that measurement of troponin proteins can be useful to guide therapeutic decisions in patients with acute coronary artery syndromes, especially regarding treatment with low-molecular-weight heparin or IIB/IIIA inhibitors. The absence of troponins in the circulation does not necessarily indicate the absence of coronary artery disease. With current assays, a significant diagnostic difference does not appear to exist between cardiac troponin I and T in patients with acute coronary artery syndromes.Keywords
This publication has 20 references indexed in Scilit:
- “Low-risk” chest pain patients may be at high risk for cardiac events: prospective use of troponin T for risk stratificationJournal of the American College of Cardiology, 1998
- Value of Serial Troponin T Measures for Early and Late Risk Stratification in Patients With Acute Coronary SyndromesCirculation, 1998
- Emergency Room Triage of Patients with Acute Chest Pain by Means of Rapid Testing for Cardiac Troponin T or Troponin INew England Journal of Medicine, 1997
- The Electrocardiogram Predicts One-Year Outcome of Patients With Unstable Angina and Non–Q Wave Myocardial Infarction: Results of the TIMI III Registry ECG Ancillary Study fn1fn1The TIMI III Clinical Centers are supported by Grant R01-HL42311 and the Data Coordinating Center by Grant R01-HL42428 from the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland. Additional support was supplied by Genentech, Inc., South San Francisco, California.Journal of the American College of Cardiology, 1997
- Cardiac-Specific Troponin I Levels to Predict the Risk of Mortality in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1996
- Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s?Circulation, 1993
- Cardiac troponin I. A marker with high specificity for cardiac injury.Circulation, 1993
- The Prognostic Value of Serum Troponin T in Unstable AnginaNew England Journal of Medicine, 1992
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992